Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products that include vaccines, parasiticides and feed additives used in both the production animal and companion animal markets. In return, Pfizer will receive an undisclosed upfront payment. The products were previously marketed by Pfizer and Wyeth’s Fort Dodge operations. The European Commission requested that Pfizer divest these products as a result of its acquisition of Wyeth...